Paul Stoffels

Last updated

Paul, Baron Stoffels (born 8 March 1962 in Turnhout, Belgium) is a Belgian doctor, who studied medicine at the University of Hasselt and the University of Antwerp (UA). In addition he studied Infectious Diseases and Tropical Medicine at the Prince Leopold Institute of Tropical Medicine in Antwerp, Belgium. He is Chief Scientific Officier, Worldwide Chairman of Janssen pharmaceuticals and he is a member of the Johnson & Johnson Executive Committee. [1]

Contents

Career

Stoffels worked for four years as a physician and researcher of HIV/AIDS and tropical diseases in Africa, where he met Peter Piot. In 1991 he returned to Belgium and became the Head of Development for the HIV compounds at Janssen Pharmaceutica in Beerse, Belgium. In 1993 he was promoted to Director of Clinical Research and Development for Infectious Diseases and Dermatology. In 1997 he left Janssen Pharmaceuticals and together with Rudi Pauwels co-founded the biotech companies Tibotec and Virco.

When Johnson & Johnson acquired Tibotec-Virco in April 2002, he became Company Group Chairman of the Global Virology Franchise at Johnson & Johnson and Chairman of Tibotec. Stoffels was the Chief Scientific Officer at Johnson & Johnson, and is responsible for the safety of all products of the Johnson & Johnson Family of Companies worldwide as well as leading teams across different sectors (CNS, pain, infectious disease, metabolism, cardiovascular disease, and primary care) to set the companywide innovation agenda.

In 2020 he received the Louis Pasteur Leadership Award in Public Health. [2]

On 12 October 2021 it was announced that Stoffels would be stepping down from his role as Chief Scientific Officer at Johnson & Johnson and into retirement, effective 31 December 2021. A successor was not named. [3]

On January 26, 2022, it was announced that Stoffels would be appointed CEO of the bio-tech company Galapagos, effectively ending his announced retirement. [4]

See also

Related Research Articles

<span class="mw-page-title-main">Beerse</span> Municipality in Flemish Community, Belgium

Beerse is a municipality located in the Belgian province of Antwerp. The municipality comprises the towns of Beerse proper and Vlimmeren. In 2021, Beerse had a total population of 18,194. The total area is 37.48 km2. The pharmaceutical company Janssen Pharmaceutica, founded by Dr. Paul Janssen, has its headquarters in Beerse.

<span class="mw-page-title-main">Turnhout</span> Municipality in Flemish Community, Belgium

Turnhout is a Belgian municipality and city located in the Flemish province of Antwerp. The municipality comprises only the city of Turnhout proper. In 2021, its population was 45,874. The total area is 56.06 km2 (21.64 sq mi). The agglomeration is much more populous, with 81,473 inhabitants. It is known for its playing card industry, and houses the head office of the world's largest manufacturer of playing cards, Cartamundi. Turnhout is also the capital of the administrative district with the same name. The city council often promotes the city as "the capital of the Kempen area". This designation is entirely unofficial, since the Kempen area is far larger than the Turnhout district and does not form an administrative unit.

<span class="mw-page-title-main">Peter Piot</span> Belgian microbiologist (born 1949)

Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.

<span class="mw-page-title-main">University of Antwerp</span> University in Antwerp, Belgium

The University of Antwerp is a major Belgian university located in the city of Antwerp. The official abbreviation is UAntwerp. The University of Antwerp has about 20,000 students, which makes it the third-largest university in Flanders. The University of Antwerp is characterised by its high standards in education, internationally competitive research and entrepreneurial approach. It was founded in 2003 after the merger of three smaller universities.

<span class="mw-page-title-main">Stanley Plotkin</span> American physician

Stanley Alan Plotkin is an American physician who works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. In the 1960s, he played a pivotal role in discovery of a vaccine against rubella virus while working at Wistar Institute in Philadelphia. Plotkin was a member of Wistar’s active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, he is emeritus professor of Pediatrics at the University of Pennsylvania. His book, Vaccines, is the standard reference on the subject. He is an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C.

<span class="mw-page-title-main">Tibotec</span>

Tibotec was a pharmaceutical company with a focus on research and development for the treatment of infectious diseases such as HIV/AIDS and hepatitis C. The company was founded in 1994 and then acquired by Johnson & Johnson and merged into its Janssen Pharmaceuticals division in 2002.

<span class="mw-page-title-main">Paul Janssen</span> Belgian scientist, founder of Janssen Pharmaceutica

Paul Adriaan Jan, Baron Janssen was a Belgian physician. He was the founder of Janssen Pharmaceutica, a pharmaceutical company with over 20,000 employees which is now a subsidiary of Johnson & Johnson.

<span class="mw-page-title-main">Janssen Pharmaceuticals</span> Belgian pharmaceutical company

Johnson & Johnson Innovative Medicine is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.

<span class="mw-page-title-main">Ortho-McNeil Pharmaceutical</span> Pharmaceutical company

The Ortho-McNeil Pharmaceutical was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993. Both of these pharmaceutical companies are pioneers and leaders in areas such as pain management, acid reflux disease, and infectious diseases. Ortho-McNeil and Janssen Pharmaceutica together compose the Ortho-McNeil-Janssen group within Johnson & Johnson.

<span class="mw-page-title-main">Rega Institute for Medical Research</span>

The Rega Institute for Medical Research is a Belgian scientific establishment that is part of the Catholic University of Leuven (Leuven) in central Belgium. The Rega Institute is an interfacultary biomedical research institute of the Catholic University of Leuven and consists of departments of medicine and pharmacology.

<span class="mw-page-title-main">Rudi Pauwels</span> Belgian pharmacologist and entrepreneur

Rudi Pauwels is a Belgian pharmacologist and biotech entrepreneur.

Didier R.G.G. de Chaffoy de Courcelles is a Belgian scientist and businessman. He was senior vice president of Drug Discovery Europe, and Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), a division of Janssen Pharmaceutica, until 2008 when he left the company.

Ajit, Baron Shetty is a Belgian businessman. He was chairman of the board of directors of Janssen Pharmaceutica, a pharmaceutical company and subsidiary of Johnson & Johnson, with its headquarters in Beerse, Belgium. In February 2012 he retired. Shetty also served as a member of the Corporate Center Group Operating Committee and Vice President of Enterprise Supply Chain for Johnson & Johnson in New Brunswick, New Jersey.

<span class="mw-page-title-main">Jaap Goudsmit</span>

Jaap Goudsmit is Dutch scientist, known for his research in the field of AIDS and influenza. He shifted his research interest to aging and neurodegenerative diseases, like Alzheimer's Disease. He is also a prolific writer of non-fiction books: Viral Sex, the Nature of AIDS (1997); Viral Fitness, the Next SARS and West Nile in the Making (2004); Serendipity Manual (2012); The Vaccine Bug, a personal history of the World of Immunity (2013); Immorbidity Alphabet, Spelling-out a life free of dis-ease (2015); The Time of your Life, Staying healthy to the End (2016) and The Art of Facing Mortality, a scientist's view (2016).

Staf Van Reet is a Belgian scientist and businessman. Currently he is Managing Director of the biotech company Viziphar Biosciences BVBA, and member of the Board of Directors of Janssen Pharmaceutica and the VIB. He was succeeded as Chairman of FlandersBio by Johan Cardoen.

Joos Horsten (1942–2008) was a Belgian businessman. He founded Xian Janssen Pharmaceutical, the Sino-Belgian joint venture of Janssen Pharmaceutica, a Flemish pharmaceutical company in Belgium.

Paul J. Lewi was a Belgian scientist, who elaborated Spectral Map Analysis in 1975 and was one of the cofounders of chemometrics in 1983. Paul Lewi was married with Godelieve Debruyne and they have together 3 children and with Philomena Van Bylen, with 2 children.

Koen Andries is a Belgian Janssen Pharmaceutica scientist and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di-Aryl-Quinoline-based drug (R207910), now called bedaquiline, which promises a shorter and simpler treatment for drug resistant Tuberculosis (TB).

The Dr. Paul Janssen Award for Biomedical Research is given annually by Johnson & Johnson to honor the work of an active scientist in academia, industry or a scientific institute in the field of biomedical research. It was established in 2004 and perpetuates the memory of Paul Janssen, the founder of Janssen Pharmaceutica, a Johnson & Johnson subsidiary.

Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.

References

  1. ↑ "Paul Stoffels, M.D." Janssen. Retrieved 18 March 2020.
  2. ↑ US, Pasteur Foundation. "Paul Stoffels, M.D., The Honorable Jane Hartley, and Janet Tobias Honored With 2020 Pasteur Foundation Awards". www.prnewswire.com. Retrieved 24 March 2020.
  3. ↑ "Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021". J&J.
  4. ↑ "Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO". Reuters. 26 January 2022. Retrieved 16 March 2022.

Sources


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.